recent publications
-
academic article
- Amelio, A. L., Fallahi, M., Schaub, F. X., Zhang, M., Lawani, M. B., Alperstein, A. S., Southern, M. R., Young, B. M., Wu, L., Zajac-Kaye, M., Kaye, F. J., Cleveland, J. L., et al. CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement Proceedings of the National Academy of Sciences of the United States of America 2014 111:E3260-E3268 DOI:10.1073/pnas.1319176111 PMID:25071166 PMCID:PMC4136562
- Bonsignori, M., Hwang, K. K., Chen, X., Tsao, C. Y., Morris, L., Gray, E., Marshall, D. J., Crump, J. A., Kapiga, S. H., Sam, N. E., Sinangil, F., Pancera, M., et al. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors Journal of Virology 2011 85:9998-10009 DOI:10.1128/jvi.05045-11 PMID:21795340 PMCID:PMC3196428
- Wu, X. L., Zhou, T. Q., Zhu, J., Zhang, B. S., Georgiev, I., Wang, C., Chen, X. J., Longo, N. S., Louder, M., McKee, K., O'Dell, S., Perfetto, S., et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing Science 2011 333:1593-1602 DOI:10.1126/science.1207532 PMID:21835983 PMCID:PMC3516815
- Liu, S. J., Yu, Z. H., Yu, X. A., Huang, S. X., Luo, Y. G., Wu, L., Shen, W. H., Yang, Z. Y., Wang, L. N., Gunawan, A. M., Chan, R. J., Shen, B., et al. Shp2 is a target of the immunosuppressant tautomycetin Chemistry & Biology 2011 18:101-110 DOI:10.1016/j.chembiol.2010.10.015 PMID:21276943 PMCID:PMC3034256
- Wu, X. L., Yang, Z. Y., Li, Y. X., Hogerkorp, C. M., Schief, W. R., Seaman, M. S., Zhou, T. Q., Schmidt, S. D., Wu, L., Xu, L., Longo, N. S., McKee, K., et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to hiv-1 Science 2010 329:856-861 DOI:10.1126/science.1187659 PMID:20616233 PMCID:PMC2965066
- Wu, L., Zhou, T. Q., Yang, Z. Y., Svehla, K., O'Dell, S., Louder, M. K., Xu, L., Mascola, J. R., Burton, D. R., Hoxie, J. A., Doms, R. W., Kwong, P. D., et al. Enhanced exposure of the cd4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain Journal of Virology 2009 83:5077-5086 DOI:10.1128/jvi.02600-08 PMID:19264769 PMCID:PMC2682083
- Suzuki, H., Forrest, A. R. R., van Nimwegen, E., Daub, C. O., Balwierz, P. J., Irvine, K. M., Lassmann, T., Ravasi, T., Hasegawa, Y., de Hoon, M. J. L., Katayama, S., Schroder, K., et al. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line Nature Genetics 2009 41:553-562 DOI:10.1038/ng.375 PMID:19377474
- Lieberson, R., Mowen, K. A., McBride, K. D., Leautaud, V., Zhang, X. K., Suh, W. K., Wu, L., Glimcher, L. H. Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45) Journal of Experimental Medicine 2001 194:89-98 DOI:10.1084/jem.194.1.89 PMID:11435475 PMCID:PMC2193447
- Baldwin, K. K., Reay, P. A., Wu, L., Farr, A., Davis, M. M. A T cell receptor-specific blockade of positive selection Journal of Experimental Medicine 1999 189:13-23 DOI:10.1084/jem.189.1.13 PMID:9874560 PMCID:PMC1887687
- Wu, L., Pearse, M., Egerton, M., Petrie, H., Scollay, R. CD4-CD8- thymocytes that express the T-cell receptor may have previously expressed CD8 International Immunology 1990 2:51-56 DOI:10.1093/intimm/2.1.51 PMID:2150920